In an era of rising patient expectations and rapidly evolving healthcare standards, The Trust Hospital Company Ltd stands out ...

ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.

Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lilly’s Kisunla (donanemab) in July ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

Top radiology experts, researchers, innovators and healthcare professionals gathered in Dubai today for the 13th Pan-Arab ...

Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, today presented positive preclinical data demonstrating the satisfactory ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Mpox and Smallpox Threats: Vaccine Development and Biosecurity Policy ...

Building upon significant strides in the capacity and coverage of the National Blood Transfusion Service (NBTS), Eritrea has taken a crucial step to fortify blood safety with the official launch of ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one monthA second pediatric ...